CUTANEOUS T-CELL LYMPHOMA STAGE I

This adverse event was reported 36 times

These drugs are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE I:

# Drug Count
0 DUPILUMAB 12
1 ALLOPURINOL 9
2 ANTACID 9
3 BEXAROTENE 9
4 CALCIUM CARBONATE 9
5 FILGRASTIM 9
6 FUROSEMIDE 9
7 MEROPENEM 9
8 METHOTREXATE 9
9 METHOTREXATE SODIUM 9
See all common drugs associated with CUTANEOUS T-CELL LYMPHOMA STAGE I

CUTANEOUS T-CELL LYMPHOMA STAGE I is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEXAROTENE 9 0.0068
1 RASBURICASE 9 0.0036
2 VANCOMYCIN HYDROCHLORIDE 9 0.0011
3 PIPERACILLIN SODIUM,TAZOBACTAM SODIUM 9 0.0003
4 PIPERACILLIN AND TAZOBACTAM 4 0.0003
5 MEROPENEM 9 0.0003
6 FILGRASTIM 9 0.0002
7 PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 4 0.0002
8 FINGOLIMOD HYDROCHLORIDE 1 0.0002
9 GOLIMUMAB 2 0.0002
See all drugs enriched for association with CUTANEOUS T-CELL LYMPHOMA STAGE I